Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1050 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Brigatinib (Alunbrig) for anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer	Brigatinib (Alunbrig; AP26113)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2017	View \| Download
Brexanolone for postpartum depression	Brexanolone (SAGE-547; Zulresso)	Postnatal depression	Mental and Behavioural Health	2019	View \| Download
Brentuximab vedotin with doxorubicin, dacarbazine and vinblastine for previously untreated late-stage classical Hodgkin lymphoma	Brentuximab vedotin (Adcetris; SGN-35) , Dacarbazine (dacarbazine citrate) , Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride) , Vinblastine (vinblastine sulfate)	Hodgkin lymphoma	Haematological Cancer and Lymphomas	2023	View \| Download
Brentuximab vedotin in addition to cyclophosphamide, doxorubicin, and prednisolone (CHP) for CD30+ mature T-cell lymphoma	Brentuximab vedotin (Adcetris; SGN-35) , CHP	Mature T-cell lymphoma	Haematological Cancer and Lymphomas	2018	View \| Download
Brentuximab vedotin (Adcetris) for treatment naive Hodgkin’s Lymphoma	Adriamycin , Brentuximab vedotin (Adcetris; SGN-35) , Dacarbazine (dacarbazine citrate) , Vinblastine (vinblastine sulfate)	Hodgkin lymphoma	Haematological Cancer and Lymphomas	2017	View \| Download
BPX‐501 to improve Immune Recovery and Graft versus Host Disease (GvHD) after Haploidentical Stem Cell Transplant	Rivogenlecleucel (BPX-501)	Graft versus host disease (GvHD) , Immunodeficiency	Immunology	2018	View \| Download
Botaretigene sparoparvovec for treating X-linked retinitis pigmentosa	Botaretigene sparoparvovec	Retinitis pigmentosa	Ophthalmology	2023	View \| Download
Bosutinib (Bosulif) for Philadelphia positive chronic myeloid leukaemia – first line	Bosutinib (Bosulif; PF-05208763; bosutinib monohydrate)	Chronic myeloid leukaemia (CML)	Haematological Cancer and Lymphomas	2017	View \| Download
BMS-986165 for moderate to severe plaque psoriasis	Deucravacitinib (BMS-986165)	Plaque psoriasis	Dermatology	2020	View \| Download
Blinatumomab (Blincyto) for First Relapsed/Refractory, B-precursor, Acute Lymphoblastic Leukaemia, in Children and Adolescents	Blinatumomab (Blincyto)	Acute lymphoblastic leukaemia (ALL)	Haematological Cancer and Lymphomas	2017	View \| Download